Venturepharm Group

Venturepharm Laboratories Limited (Stock Code: 8225.HK) is a leading fully integrated pharmaceutical powerhouse based in China.
APIs: Adapalene, Voriconazole, Alendronate Sodium, Riluzole, Letrozole, Loratadine, Loteprednol Etabonate, Risedronate Sodium, Zidovudine, Memantine HCl, etc.

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Manufacturing
- Regulatory Affairs & Legal Services
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- API / chemicals
- Generics
- FP (finished products)

Therapeutic targets:

- AIDS
- Allergy
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Dermatology
- Diabetes
- Gastrointestinal
- Infectious Diseases
- Neurology
- Oncology
- Ophthalmology
- Pain
- Urology

Markets Covered

a. HeadQuarter: China

b. Continent(s) active: Asia , Europe , Central/South America , North America , Near/Middle East , Far East , Africa , Australia/New-Zealand

c. Countries active: EU, USA, Brazil, Korea, Egypt, Malaysia, etc.

Corporate data:

Number of Employees: 500

Turnover:

Amount:	Year:	Currency:
16, 000, 000	2002	US Dollar

Year founded: 1998

Stock options:

	Symbol	Exchange
1	HK	8225